Turmeric and honey contain beneficial compounds that can help reduce inflammation, improve metabolic health, and aid in ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

Dr. Heidenreich notes that among the 86% of seminoma CSI patients, 15-30% relapse, of which 95% relapse in the retroperitoneum, nearly all relapses have good prognosis, and these patients are now CS ...

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for ADCETRIS® (brentuximab vedotin) in combination with ...

Pfizer Inc. (NYSE: PFE) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced additional follow-up ...

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...

In fact, many anti-oxidant drugs are used for the treatment of type 1 diabetes mellitus in the clinical ... and anti-oxidant systems of cells and has been used to treat acute poisoning and chronic ...

Particularly, type 2 diabetes mellitus (T2DM ... and by improving glucose toxicity, the function of pancreatic β cells can be maintained. These are diabetic treatment agents with a low risk of ...

Although the patient's serum tacrolimus level was high suggesting tacrolimus toxicity, his symptoms did not improve ... polyneuropathy and polyneuropathy due to renal disease or diabetes mellitus. The ...

non-insulin-dependent type II diabetes mellitus, hyperlipidaemia, hypertension, obstructive sleep apnoea, rheumatoid arthritis (RA) with associated pulmonary nodulosis and Sjogren’s syndrome. A prior ...

A new study reveals that diabetes significantly accelerates the emergence and spread of antibiotic-resistant Staphylococcus ...

Researchers have proven that antibiotic-resistant strains of a harmful bacteria thrive in a diabetic infection environment.